[go: up one dir, main page]

IN2014MU00203A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00203A
IN2014MU00203A IN203MU2014A IN2014MU00203A IN 2014MU00203 A IN2014MU00203 A IN 2014MU00203A IN 203MU2014 A IN203MU2014 A IN 203MU2014A IN 2014MU00203 A IN2014MU00203 A IN 2014MU00203A
Authority
IN
India
Prior art keywords
compound
trazodone
preparation
provides
hydrochloride
Prior art date
Application number
Inventor
Shashikant Kadam
Narender Rao Somisetti
Srinivas Ashili
Narsimulu Raigoni
Original Assignee
Piramal Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Entpr Ltd filed Critical Piramal Entpr Ltd
Priority to EP14879353.2A priority Critical patent/EP3097099A4/en
Priority to CA2937417A priority patent/CA2937417C/en
Priority to IN203MU2014 priority patent/IN2014MU00203A/en
Priority to JP2016547540A priority patent/JP2017505302A/en
Priority to PCT/IB2014/066841 priority patent/WO2015110883A1/en
Publication of IN2014MU00203A publication Critical patent/IN2014MU00203A/en
Priority to IL246835A priority patent/IL246835A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The present invention provides an improved process for preparation of the substantially pure trazodone and its hydrochloride salt. The process comprises reaction of the compound-II (as described) with the compound-Ill (as described) optionally in the presence of an inorganic base, and a catalyst; wherein in the said process the trazodone free base and/or its hydrochloride salt are isolated by precipitation at lower temperature. The improved process for the preparation of trazodone hydrochloride (the compound I) provides the product with total amount of alkylating substances (as described herein) as impurity in less than 10 ppm. The improved process for the preparation of trazodone hydrochloride (the compound I) provides the product with total amount of l-(3-chlorophenyl)-4-(3-chloropropyl) piperazine as an impurity in less than 2.5 ppm.
IN203MU2014 2014-01-21 2014-12-12 IN2014MU00203A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP14879353.2A EP3097099A4 (en) 2014-01-21 2014-12-12 An improved process for the preparation of trazodone and hydrochloride salt thereof
CA2937417A CA2937417C (en) 2014-01-21 2014-12-12 An improved process for the preparation of trazodone and hydrochloride salt thereof
IN203MU2014 IN2014MU00203A (en) 2014-01-21 2014-12-12
JP2016547540A JP2017505302A (en) 2014-01-21 2014-12-12 Improved process for producing trazodone and its hydrochloride
PCT/IB2014/066841 WO2015110883A1 (en) 2014-01-21 2014-12-12 An improved process for the preparation of trazodone and hydrochloride salt thereof
IL246835A IL246835A0 (en) 2014-01-21 2016-07-19 An improved process for the preparation of trazodone and hydrochloride salt thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN203MU2014 IN2014MU00203A (en) 2014-01-21 2014-12-12

Publications (1)

Publication Number Publication Date
IN2014MU00203A true IN2014MU00203A (en) 2015-09-25

Family

ID=53680891

Family Applications (1)

Application Number Title Priority Date Filing Date
IN203MU2014 IN2014MU00203A (en) 2014-01-21 2014-12-12

Country Status (6)

Country Link
EP (1) EP3097099A4 (en)
JP (1) JP2017505302A (en)
CA (1) CA2937417C (en)
IL (1) IL246835A0 (en)
IN (1) IN2014MU00203A (en)
WO (1) WO2015110883A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL234822B1 (en) 2017-03-14 2020-04-30 Politechnika Krakowska Im Tadeusza Kosciuszki Method for obtaining trazodone
CN117517545A (en) * 2023-12-08 2024-02-06 重庆锐恩医药有限公司 Method for detecting trazodone hydrochloride related substances

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (en) * 1965-12-15 1985-03-12 Acraf DERIVATIVES OF S IPIAZOLE 4.3 A PYRIDIN AND PROCESSES FOR THEIR PREPARATION
US4252806A (en) * 1979-09-24 1981-02-24 Mead Johnson & Company Triazoloquinolones
HU201324B (en) * 1988-07-29 1990-10-28 Egyt Gyogyszervegyeszeti Gyar New process for production of substituated 1,2,4-triasole (4,3-a)-piridin-2 (2h)-on
ITMI20071603A1 (en) * 2007-08-03 2009-02-04 Acraf TRAZODONE AND CHLORIDATED TRAZODONE IN PURIFIED FORM
US20090209550A1 (en) * 2008-02-20 2009-08-20 Auspex Pharmaceuticals, Inc. Substituted triazolopyridines

Also Published As

Publication number Publication date
EP3097099A4 (en) 2017-08-23
IL246835A0 (en) 2016-08-31
CA2937417A1 (en) 2015-07-30
CA2937417C (en) 2022-04-12
WO2015110883A1 (en) 2015-07-30
EP3097099A1 (en) 2016-11-30
JP2017505302A (en) 2017-02-16

Similar Documents

Publication Publication Date Title
TW201613886A (en) 3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones
TN2016000270A1 (en) Heteroaryls and uses thereof.
MX2016011992A (en) Piperidine-dione derivatives.
TW201613872A (en) IRAK4 inhibiting agents
PH12017500821A1 (en) Morpholine and 1, 4-oxazepane amides as somatostatin receptor subtype 4 (sstr4) agonists
TN2014000058A1 (en) A Novel 1,2,3,4-Tetrahydroquinoline Derivative Useful for the Treatment of Diabetes
PH12014501365A1 (en) Compounds
MD4820B1 (en) Substituted dihydroisoquinolinone compounds
SA113340696B1 (en) Manufacture of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-Yl)-4h-1,2,4-triazol-3-ylthio)acetic acid
MY197698A (en) Oxysterols and methods of use thereof
SG10201804026WA (en) Inhibitors of influenza viruses replication
NZ718373A (en) Substituted piperidyl-ethyl-pyrimidine as ghrelin o-acyl transferase inhibitor
MY183123A (en) Synthesis of copanlisib and its di hydrochloride salt
PH12014501712A1 (en) Novel morpholinyl derivatives useful as mogat-2-inhibitors
MX359069B (en) Salt and crystal forms of plk-4 inhibitor.
EP3057935A4 (en) Process for forming primary, secondary or tertiary amine via direct amination reaction
PH12015501146A1 (en) Hydantoin derivative
WO2012147091A3 (en) Process for rilpivirine
PH12018500999A1 (en) Sodium channel blocker
MX350430B (en) Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-m ethyl-pentanoic acid compounds.
IN2014MU00203A (en)
UA117524C2 (en) Plant stimulators, use thereof and method of plant stimulation
IN2012DN02000A (en)
PH12014501313B1 (en) Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
IN2014MU00072A (en)